{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T04:58:53Z","timestamp":1778821133961,"version":"3.51.4"},"reference-count":116,"publisher":"Elsevier BV","issue":"3-4","license":[{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression"],"published-print":{"date-parts":[[2006,3]]},"DOI":"10.1016\/j.bbaexp.2006.03.006","type":"journal-article","created":{"date-parts":[[2006,5,3]],"date-time":"2006-05-03T09:09:41Z","timestamp":1146647381000},"page":"117-131","source":"Crossref","is-referenced-by-count":38,"title":["DNA topoisomerase I from parasitic protozoa: A potential target for chemotherapy"],"prefix":"10.1016","volume":"1759","author":[{"given":"R.M.","family":"Reguera","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.M.","family":"Redondo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Gutierrez de Prado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"P\u00e9rez-Pertejo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Bala\u00f1a-Fouce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbaexp.2006.03.006_bib1","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1016\/S0140-6736(05)66420-3","article-title":"Malaria","volume":"365","author":"Greenwood","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.bbaexp.2006.03.006_bib2","doi-asserted-by":"crossref","first-page":"623","DOI":"10.2174\/1566524043360096","article-title":"The structure and replication of kinetoplast DNA","volume":"4","author":"Shlomai","year":"2004","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/j.bbaexp.2006.03.006_bib3","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/nrmicro848","article-title":"Human African trypanosomiasis","volume":"2","author":"Kioy","year":"2004","journal-title":"Nat. Rev., Microbiol."},{"key":"10.1016\/j.bbaexp.2006.03.006_bib4","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1136\/bmj.326.7404.1444","article-title":"American trypanosomiasis (Chagas' disease) and the role of molecular epidemiology in guiding control strategies","volume":"326","author":"Miles","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.bbaexp.2006.03.006_bib5","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.cimid.2004.03.004","article-title":"Leishmaniasis: current situation and new perspectives","volume":"27","author":"Desjeux","year":"2004","journal-title":"Comp. Immunol. Microbiol. Infect. Dis."},{"key":"10.1016\/j.bbaexp.2006.03.006_bib6","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.pt.2003.08.001","article-title":"Chemoresistance in falciparum malaria","volume":"19","author":"May","year":"2003","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.bbaexp.2006.03.006_bib7","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1046\/j.1472-8206.2003.00164.x","article-title":"The mechanisms of resistance to antimalarial drugs in Plasmodium falciparum","volume":"17","author":"Le Bras","year":"2003","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.bbaexp.2006.03.006_bib8","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1097\/01.qco.0000186848.46417.6c","article-title":"Artemisinin-based combinations","volume":"18","author":"Ashley","year":"2005","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.bbaexp.2006.03.006_bib9","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S1473-3099(02)00321-3","article-title":"Treatment of human African trypanosomiasis\u2014Present situation and needs for research and development","volume":"2","author":"Legros","year":"2002","journal-title":"Lancet, Infect. Dis."},{"key":"10.1016\/j.bbaexp.2006.03.006_bib10","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1172\/JCI200421052","article-title":"Human African trypanosomiasis of the CNS: current issues and challenges","volume":"113","author":"Kennedy","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbaexp.2006.03.006_bib11","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1046\/j.1365-3156.2002.00933.x","article-title":"Combination of eflornithine and melarsoprol for melarsoprol-resistant Gambian trypanosomiasis","volume":"7","author":"Mpia","year":"2002","journal-title":"Trop. Med. Int. Health"},{"key":"10.1016\/j.bbaexp.2006.03.006_bib12","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.pt.2003.09.001","article-title":"Specific chemotherapy of Chagas' disease: controversies and advances","volume":"19","author":"Urbina","year":"2003","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.bbaexp.2006.03.006_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0009-2797(90)90106-W","article-title":"Sensitivity of parasites to free radical damage by antiparasitic drugs","volume":"73","author":"Docampo","year":"1990","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.bbaexp.2006.03.006_bib14","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.pt.2003.09.008","article-title":"Leishmaniasis\u2014Current chemotherapy and recent advances in the search for novel drugs","volume":"19","author":"Croft","year":"2003","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.bbaexp.2006.03.006_bib15","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0306-3623(97)00268-1","article-title":"The pharmacology of leishmaniasis","volume":"30","author":"Bala\u00f1a-Fouce","year":"1998","journal-title":"Gen. Pharmacol."},{"key":"10.1016\/j.bbaexp.2006.03.006_bib16","first-page":"24","article-title":"Leishmaniasis\u2014Oral treatment with hexadecylphosphocholine","volume":"116","author":"Bommer","year":"2004","journal-title":"Wien Klin. Wochenschr."},{"key":"10.1016\/j.bbaexp.2006.03.006_bib17","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.pt.2004.05.005","article-title":"Virulence and disease in leishmaniasis: what is relevant for the patient?","volume":"20","author":"Rivas","year":"2004","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.bbaexp.2006.03.006_bib18","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.idc.2004.10.002","article-title":"The impact of HIV infection on tropical diseases","volume":"19","author":"Harms","year":"2005","journal-title":"Infect. Dis. Clin. North Am."},{"key":"10.1016\/j.bbaexp.2006.03.006_bib19","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/S1473-3099(01)00007-X","article-title":"Sharing needles may produce artificial Leishmania cycle","volume":"1","author":"Burton","year":"2001","journal-title":"Lancet, Infect. Dis."},{"key":"10.1016\/j.bbaexp.2006.03.006_bib20","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1146\/annurev.biochem.70.1.369","article-title":"DNA topoisomerases: structure, function, and mechanism","volume":"70","author":"Champoux","year":"2001","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.bbaexp.2006.03.006_bib21","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/nrm831","article-title":"Cellular roles of DNA topoisomerases: a molecular perspective","volume":"3","author":"Wang","year":"2002","journal-title":"Nat. Rev., Mol. Cell Biol."},{"key":"10.1016\/j.bbaexp.2006.03.006_bib22","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1146\/annurev.biophys.33.110502.140357","article-title":"Structure, molecular mechanisms, and evolutionary relationships in DNA topoisomerases","volume":"33","author":"Corbett","year":"2004","journal-title":"Annu. Rev. Biophys. Biomol. Struct."},{"key":"10.1016\/j.bbaexp.2006.03.006_bib23","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1146\/annurev.bi.65.070196.003223","article-title":"DNA topoisomerases","volume":"65","author":"Wang","year":"1996","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.bbaexp.2006.03.006_bib24","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0167-4781(98)00124-9","article-title":"Structure of DNA topoisomerases","volume":"1400","author":"Berger","year":"1998","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbaexp.2006.03.006_bib25","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1093\/nar\/22.13.2547","article-title":"The gene encoding topoisomerase II from Plasmodium falciparum","volume":"22","author":"Cheesman","year":"1994","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbaexp.2006.03.006_bib26","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0166-6851(90)90214-7","article-title":"The TOP2 gene of Trypanosoma brucei: a single-copy gene that shares extensive homology with other TOP2 genes encoding eukaryotic DNA topoisomerase II","volume":"38","author":"Strauss","year":"1990","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.bbaexp.2006.03.006_bib27","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0166-6851(92)90133-5","article-title":"Cloning and characterization of the gene encoding Trypanosoma cruzi DNA topoisomerase II","volume":"55","author":"Fragoso","year":"1992","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.bbaexp.2006.03.006_bib28","first-page":"28S","article-title":"Identification of a type II topoisomerase gene from Cryptosporidium parvum","volume":"41","author":"Christopher","year":"1994","journal-title":"J. Eukaryot. Microbiol."},{"key":"10.1016\/j.bbaexp.2006.03.006_bib29","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1093\/nar\/29.9.1844","article-title":"Characterisation of the gene encoding type II DNA topoisomerase from Leishmania donovani: a key molecular target in antileishmanial therapy","volume":"29","author":"Das","year":"2001","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbaexp.2006.03.006_bib30","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1126\/science.279.5356.1534","article-title":"A model for the mechanism of human topoisomerase I","volume":"279","author":"Stewart","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.bbaexp.2006.03.006_bib31","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0079-6603(08)60891-0","article-title":"Domains of human topoisomerase I and associated functions","volume":"60","author":"Champoux","year":"1998","journal-title":"Prog. Nucleic Acid Res. Mol. Biol."},{"key":"10.1016\/j.bbaexp.2006.03.006_bib32","doi-asserted-by":"crossref","first-page":"7602","DOI":"10.1074\/jbc.271.13.7602","article-title":"The domain organization of DNA topoisomerase I","volume":"271","author":"Stewart","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbaexp.2006.03.006_bib33","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1126\/science.279.5356.1504","article-title":"Crystal structures of human topoisomerase I in covalent and noncovalent complexes with DNA","volume":"279","author":"Redinbo","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.bbaexp.2006.03.006_bib34","doi-asserted-by":"crossref","first-page":"25820","DOI":"10.1074\/jbc.M002144200","article-title":"Expression of human topoisomerase I with a partial deletion of the linker region yields monomeric and dimeric enzymes that respond differently to camptothecin","volume":"275","author":"Ireton","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbaexp.2006.03.006_bib35","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1021\/bi00355a001","article-title":"Purification and characterization of Plasmodium berghei DNA topoisomerases I and II: drug action, inhibition of decatenation and relaxation, and stimulation of DNA cleavage","volume":"25","author":"Riou","year":"1986","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbaexp.2006.03.006_bib36","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0378-1119(95)00376-H","article-title":"The gene encoding topoisomerase I from the human parasite Plasmodium falciparum","volume":"163","author":"Tosh","year":"1995","journal-title":"Gene"},{"key":"10.1016\/j.bbaexp.2006.03.006_bib37","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1006\/expr.1998.4362","article-title":"Plasmodium falciparum: stage-related expression of topoisomerase I","volume":"91","author":"Tosh","year":"1999","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.bbaexp.2006.03.006_bib38","doi-asserted-by":"crossref","first-page":"3521","DOI":"10.1074\/jbc.M203991200","article-title":"A novel active DNA topoisomerase I in Leishmania donovani","volume":"278","author":"Villa","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbaexp.2006.03.006_bib39","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1093\/nar\/30.3.794","article-title":"An insight into the active site of a type I topoisomerase from the kinetoplastid protozoan Leishmania donovani","volume":"30","author":"Das","year":"2002","journal-title":"Nucleic Acid. Res."},{"key":"10.1016\/j.bbaexp.2006.03.006_bib40","doi-asserted-by":"crossref","first-page":"7344","DOI":"10.1073\/pnas.1330762100","article-title":"An unusual type IB topoisomerase from African trypanosomes","volume":"100","author":"Bodley","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbaexp.2006.03.006_bib41","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.febslet.2004.03.078","article-title":"Reconstitution and functional characterization of the unusual bi-subunit type I DNA topoisomerase from Leishmania donovani","volume":"565","author":"Das","year":"2004","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbaexp.2006.03.006_bib42","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1006\/jmbi.1997.1056","article-title":"Reconstitution of a human topoisomerase I by fragment complementation","volume":"269","author":"Stewart","year":"1997","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bbaexp.2006.03.006_bib43","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s004120050299","article-title":"Two separate conserved domains of eukaryotic DNA topoisomerase I bind to each other and reconstitute enzymatic activity","volume":"107","author":"Park","year":"1998","journal-title":"Chromosoma"},{"key":"10.1016\/j.bbaexp.2006.03.006_bib44","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.jmb.2006.01.022","article-title":"The structure of the transition state of the heterodimeric topoisomerase I of Leishmania donovani as a vanadate complex","volume":"357","author":"Davies","year":"2006","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bbaexp.2006.03.006_bib45","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1006\/excr.1995.1071","article-title":"Cell cycle-specific and transcription-related phosphorylation of mammalian topoisomerase I","volume":"217","author":"D'Arpa","year":"1995","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.bbaexp.2006.03.006_bib46","doi-asserted-by":"crossref","first-page":"16335","DOI":"10.1074\/jbc.M412417200","article-title":"N-Terminal region of the large subunit of Leishmania donovani bisubunit topoisomerase I is involved in DNA relaxation and interaction with the smaller subunit","volume":"280","author":"Das","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbaexp.2006.03.006_bib47","doi-asserted-by":"crossref","first-page":"4674","DOI":"10.1093\/emboj\/20.17.4674","article-title":"RNA interference of a trypanosome topoisomerase II causes progressive loss of mitochondrial DNA","volume":"20","author":"Wang","year":"2001","journal-title":"EMBO J."},{"key":"10.1016\/j.bbaexp.2006.03.006_bib48","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.molbiopara.2004.04.006","article-title":"RNA interference of Trypanosoma brucei topoisomerase IB: both subunits are essential","volume":"136","author":"Bakshi","year":"2004","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.bbaexp.2006.03.006_bib49","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.pt.2004.06.005","article-title":"Topoisomerases of kinetoplastid parasites as potential chemotherapeutic targets","volume":"20","author":"Das","year":"2004","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.bbaexp.2006.03.006_bib50","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1093\/nar\/27.13.2745","article-title":"Characterization of a Leishmania donovani gene encoding a protein that closely resembles a type IB topoisomerase","volume":"27","author":"Broccoli","year":"1999","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbaexp.2006.03.006_bib51","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/S0092-8674(00)81411-7","article-title":"Conservation of structure and mechanism between eukaryotic topoisomerase I and site-specific recombinases","volume":"92","author":"Cheng","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.bbaexp.2006.03.006_bib52","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1080\/00034989957781","article-title":"Genomic organization, transcription, splicing and gene regulation in Leishmania","volume":"93","author":"Stiles","year":"1999","journal-title":"Ann. Trop. Med. Parasitol."},{"key":"10.1016\/j.bbaexp.2006.03.006_bib53","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0065-230X(01)80016-6","article-title":"Topoisomerase I-mediated DNA damage","volume":"80","author":"Pourquier","year":"2001","journal-title":"Adv. Cancer Res."},{"key":"10.1016\/j.bbaexp.2006.03.006_bib54","doi-asserted-by":"crossref","first-page":"24159","DOI":"10.1074\/jbc.272.39.24159","article-title":"Ubiquitin-dependent destruction of topoisomerase I is stimulated by the antitumor drug camptothecin","volume":"272","author":"Desai","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbaexp.2006.03.006_bib55","first-page":"5926","article-title":"Ubiquitin\/26S proteasome-mediated degradation of topoisomerase I as a resistance mechanism to camptothecin in tumor cells","volume":"61","author":"Desai","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbaexp.2006.03.006_bib56","doi-asserted-by":"crossref","first-page":"429","DOI":"10.2174\/1568011043352777","article-title":"Camptothecins and topoisomerase I: a foot in the door. Targeting the genome beyond topoisomerase I with camptothecins and novel anticancer drugs: importance of DNA replication, repair and cell cycle checkpoints","volume":"4","author":"Pommier","year":"2004","journal-title":"Curr. Med. Chem. Anticancer Agents"},{"key":"10.1016\/j.bbaexp.2006.03.006_bib57","first-page":"3535","article-title":"Enhanced chemosensitivity to CPT-11 with proteasome inhibitor PS-341: implications for systematic nuclear factor-kB inhibition","volume":"61","author":"Cusack","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbaexp.2006.03.006_bib58","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0166-6851(99)00022-5","article-title":"Isolation and subunit composition of the 20S proteasome of Giardia lamblia","volume":"100","author":"Emmerlich","year":"1999","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.bbaexp.2006.03.006_bib59","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1042\/0264-6021:3440349","article-title":"Alpha5 subunit in Trypanosoma brucei proteasome can self-assemble to form a cylinder of four stacked heptamer rings","volume":"344","author":"Yao","year":"1999","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbaexp.2006.03.006_bib60","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1021\/bi001659k","article-title":"The ubiquitin-proteasome pathway plays an essential role in proteolysis during Trypanosoma cruzi remodeling","volume":"40","author":"Diego","year":"2001","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbaexp.2006.03.006_bib61","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0166-6851(99)00110-3","article-title":"The Leishmania mexicana proteasome","volume":"103","author":"Robertson","year":"1999","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.bbaexp.2006.03.006_bib62","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s004360050569","article-title":"Primary sequence of a putative non-ATPase subunit of the 26S proteasome from Entamoeba histolytica is similar to the human and yeast S2 subunit","volume":"85","author":"Hellberg","year":"1999","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.bbaexp.2006.03.006_bib63","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1006\/expr.1999.4442","article-title":"Cloning and partial characterization of the proteasome S4 ATPase from Plasmodium falciparum","volume":"93","author":"Certad","year":"1999","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.bbaexp.2006.03.006_bib64","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1051\/parasite\/2001084267","article-title":"Evidence for the existence of a proteasome in Toxoplasma gondii: intracellular localization and specific peptidase activities","volume":"8","author":"Paugam","year":"2001","journal-title":"Parasite"},{"key":"10.1016\/j.bbaexp.2006.03.006_bib65","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S1471-4922(02)00064-8","article-title":"Characterization and role of protozoan parasite proteosomes","volume":"19","author":"Paugam","year":"2003","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.bbaexp.2006.03.006_bib66","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/nature01099","article-title":"Genome sequence and comparative analysis of the model rodent malaria parasite Plasmodium yoelii yoelii","volume":"419","author":"Carlton","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.bbaexp.2006.03.006_bib67","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1126\/science.1112642","article-title":"The genome of the African trypanosome Trypanosoma brucei","volume":"309","author":"Berriman","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.bbaexp.2006.03.006_bib68","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1126\/science.1112631","article-title":"The genome sequence of Trypanosoma cruzi, etiologic agent of Chagas disease","volume":"309","author":"El-Sayed","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.bbaexp.2006.03.006_bib69","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1126\/science.1112680","article-title":"The genome of the kinetoplastid parasite, Leishmania major","volume":"309","author":"Ivens","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.bbaexp.2006.03.006_bib70","doi-asserted-by":"crossref","first-page":"4046","DOI":"10.1073\/pnas.080536597","article-title":"SUMO-1 conjugation to topoisomerase I: a possible repair response to topoisomerase-mediated DNA damage","volume":"97","author":"Mao","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbaexp.2006.03.006_bib71","doi-asserted-by":"crossref","first-page":"7913","DOI":"10.1038\/sj.onc.1205917","article-title":"SUMO-1 conjugation to intact DNA topoisomerase I amplifies cleavable complex formation induced by camptothecin","volume":"21","author":"Horie","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.bbaexp.2006.03.006_bib72","doi-asserted-by":"crossref","first-page":"2958","DOI":"10.1074\/jbc.M108263200","article-title":"Nucleolar delocalization of human topoisomerase I in response to topotecan correlates with sumoylation of the protein","volume":"277","author":"Mo","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbaexp.2006.03.006_bib73","doi-asserted-by":"crossref","first-page":"12654","DOI":"10.1074\/jbc.M009476200","article-title":"SUMO-1 conjugation in vivo requires both a consensus modification motif and nuclear targeting","volume":"276","author":"Rodriguez","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbaexp.2006.03.006_bib74","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0169-4758(00)01697-5","article-title":"The topoisomerases of protozoan parasites","volume":"16","author":"Chessman","year":"2000","journal-title":"Parasitol. Today"},{"key":"10.1016\/j.bbaexp.2006.03.006_bib75","doi-asserted-by":"crossref","first-page":"597","DOI":"10.2174\/1389557033487863","article-title":"DNA topoisomerases as targets for antiprotozoal chemotherapy","volume":"3","author":"Bakshi","year":"2003","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.bbaexp.2006.03.006_bib76","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1054-3589(08)60537-2","article-title":"DNA topoisomerases as targets of therapeutics: an overview","volume":"29","author":"Wang","year":"1994","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.bbaexp.2006.03.006_bib77","doi-asserted-by":"crossref","first-page":"335","DOI":"10.2174\/1568011043352885","article-title":"Development of DNA topoisomerase-related therapeutics: a short perspective of new challenges","volume":"4","author":"Capranico","year":"2004","journal-title":"Curr. Med. Chem. Anticancer Agents"},{"key":"10.1016\/j.bbaexp.2006.03.006_bib78","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1016\/S0140-6736(03)13780-4","article-title":"The camptothecins","volume":"361","author":"Pizzolato","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.bbaexp.2006.03.006_bib79","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/1568011053352596","article-title":"The impact of tumor physiology on camptothecin-based drug development","volume":"5","author":"Adams","year":"2005","journal-title":"Curr. Med. Chem. Anticancer Agents"},{"key":"10.1016\/j.bbaexp.2006.03.006_bib80","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1080\/14786410412331299005","article-title":"Camptothecin and its analogues: a review on their chemotherapeutic potential","volume":"19","author":"Sriram","year":"2005","journal-title":"Nat. Prod. Res."},{"key":"10.1016\/j.bbaexp.2006.03.006_bib81","doi-asserted-by":"crossref","first-page":"3726","DOI":"10.1073\/pnas.92.9.3726","article-title":"Molecular and cytotoxic effects of camptothecin, a topoisomerase I inhibitor, on trypanosomes and Leishmania","volume":"92","author":"Bodley","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbaexp.2006.03.006_bib82","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0006-2952(97)00556-X","article-title":"Effect of camptothecin, a topoisomerase I inhibitor on Plasmodium falciparum","volume":"55","author":"Bodley","year":"1998","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbaexp.2006.03.006_bib83","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/0006-2952(95)00215-L","article-title":"Antitrypanosomal activity of camptothecin analogs. Structure\u2013activity correlations","volume":"50","author":"Bodley","year":"1995","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbaexp.2006.03.006_bib84","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.actatropica.2005.01.005","article-title":"Anti-trypanosomal activities of DNA topoisomerase inhibitors","volume":"93","author":"Deterding","year":"2005","journal-title":"Acta Trop."},{"key":"10.1016\/j.bbaexp.2006.03.006_bib85","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1124\/pr.56.1.3","article-title":"Enzyme-catalyzed activation of anticancer pro-drugs","volume":"56","author":"Rooseboom","year":"2004","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.bbaexp.2006.03.006_bib86","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1021\/jm049146p","article-title":"Structures of three classes of anticancer agents bound to the human topoisomerase I\u2013DNA covalent complex","volume":"48","author":"Staker","year":"2005","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbaexp.2006.03.006_bib87","doi-asserted-by":"crossref","first-page":"15387","DOI":"10.1073\/pnas.242259599","article-title":"The mechanism of topoisomerase I poisoning by a camptothecin analog","volume":"99","author":"Staker","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbaexp.2006.03.006_bib88","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0959-440X(99)80005-0","article-title":"Structural insights into the function of type IB topoisomerases","volume":"9","author":"Redinbo","year":"1999","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.bbaexp.2006.03.006_bib89","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1128\/AAC.49.4.1441-1446.2005","article-title":"Topoisomerase I amino acid substitutions, Gly185Arg and Asp325Glu, confer camptothecin resistance in Leishmania donovani","volume":"49","author":"Marquis","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bbaexp.2006.03.006_bib90","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1128\/AAC.45.9.2623-2627.2001","article-title":"Treatment of visceral leishmaniasis with sterically stabilized liposomes containing camptothecin","volume":"45","author":"Proulx","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bbaexp.2006.03.006_bib91","doi-asserted-by":"crossref","first-page":"305","DOI":"10.2174\/1568026033452546","article-title":"Non-camptothecin DNA topoisomerase I inhibitors in cancer therapy","volume":"3","author":"Meng","year":"2003","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.bbaexp.2006.03.006_bib92","doi-asserted-by":"crossref","first-page":"3813","DOI":"10.1074\/jbc.M110484200","article-title":"Active site mutations in DNA topoisomerase I distinguish the cytotoxic activities of camptothecin and the indolocarbazole, rebeccamycin","volume":"277","author":"Woo","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbaexp.2006.03.006_bib93","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1124\/mol.104.003889","article-title":"Cellular topoisomerase I inhibition and antiproliferative activity by MJ-III-65 (NSC 706744), an indenoisoquinoline topoisomerase I poison","volume":"67","author":"Antony","year":"2005","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bbaexp.2006.03.006_bib94","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/0035-9203(87)90013-7","article-title":"Antiprotozoal activity of diospyrin towards Leishmania donovani promastigotes in vitro","volume":"81","author":"Hazra","year":"1987","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.bbaexp.2006.03.006_bib95","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1124\/mol.54.6.994","article-title":"Diospyrin, a bisnaphthoquinone: a novel inhibitor of type I DNA topoisomerase of Leishmania donovani","volume":"54","author":"Ray","year":"1998","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bbaexp.2006.03.006_bib96","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1124\/mol.58.1.71","article-title":"Acetyl-boswellic acids are novel catalytic inhibitors of human topoisomerases I and II","volume":"58","author":"Syrovets","year":"2000","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bbaexp.2006.03.006_bib97","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/BF03402104","article-title":"Dihydrobetulinic acid induces apoptosis in Leishmania donovani by targeting DNA topoisomerase I and II: implications in antileishmanial therapy","volume":"9","author":"Chowdhury","year":"2003","journal-title":"Mol. Med."},{"key":"10.1016\/j.bbaexp.2006.03.006_bib98","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0006-291X(88)80081-0","article-title":"Mode of action of pentavalent antimonials: specific inhibition of type I DNA topoisomerase of Leishmania donovani","volume":"152","author":"Chakraborty","year":"1988","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbaexp.2006.03.006_bib99","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1645\/GE-3347","article-title":"Inhibition of Leishmania donovani promastigote DNA topoisomerase I and human monocyte DNA topoisomerases I and II by antimonial drugs and classical antitopoisomerase agents","volume":"90","author":"Walker","year":"2004","journal-title":"J. Parasitol."},{"key":"10.1016\/j.bbaexp.2006.03.006_bib100","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1128\/AAC.42.8.1990","article-title":"Sensitivity of Leishmania viannia panamensis to pentavalent antimony is correlated with the formation of cleavable DNA\u2013protein complexes","volume":"42","author":"Lucumi","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bbaexp.2006.03.006_bib101","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1128\/AAC.34.5.918","article-title":"Berberine derivatives as antileishmanial drugs","volume":"34","author":"Vennerstrom","year":"1990","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bbaexp.2006.03.006_bib102","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1645\/GE-3161","article-title":"Effects of topoisomerases inhibitors protoberberine on Leishmania donovani growth, macrophage function, and infection","volume":"89","author":"Marquis","year":"2003","journal-title":"J. Parasitol."},{"key":"10.1016\/j.bbaexp.2006.03.006_bib103","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1055\/s-2001-17351","article-title":"In vitro effect of alkaloids on bloodstream forms of Trypanosoma brucei and T. congolense","volume":"67","author":"Merschjohann","year":"2001","journal-title":"Planta Med."},{"key":"10.1016\/j.bbaexp.2006.03.006_bib104","doi-asserted-by":"crossref","first-page":"804","DOI":"10.4269\/ajtmh.1998.58.804","article-title":"Activity of anticancer compounds against Trypanosoma cruzi-infected mice","volume":"58","author":"Kinnamon","year":"1998","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.bbaexp.2006.03.006_bib105","doi-asserted-by":"crossref","first-page":"8131","DOI":"10.1073\/pnas.90.17.8131","article-title":"DNA minor groove-binding ligands: a different class of mammalian DNA topoisomerase I inhibitors","volume":"90","author":"Chen","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbaexp.2006.03.006_bib106","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.exppara.2005.08.014","article-title":"Leishmania donovani: differential activities of classical topoisomerase inhibitors and antileishmanials against parasite and host cells at the level of DNA topoisomerase I and in cytotoxicity assays","volume":"112","author":"Jean-Moreno","year":"2006","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.bbaexp.2006.03.006_bib107","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0167-4781(98)00137-7","article-title":"Mutagenic properties of topoisomerase-targeted drugs","volume":"1400","author":"Baguley","year":"1998","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbaexp.2006.03.006_bib108","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.mrfmmm.2003.08.016","article-title":"Repair of and checkpoint response to topoisomerase I-mediated DNA damage","volume":"532","author":"Pommier","year":"2003","journal-title":"Mutat. Res."},{"key":"10.1016\/j.bbaexp.2006.03.006_bib109","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0166-6851(01)00288-2","article-title":"Identification and characterization of a RAD51 gene from Leishmania major","volume":"15","author":"McKean","year":"2001","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.bbaexp.2006.03.006_bib110","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.molbiopara.2005.03.002","article-title":"Overexpression of AP endonuclease protects Leishmania major cells against methotrexate induced DNA fragmentation and hydrogen peroxide","volume":"141","author":"Gallego","year":"2005","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.bbaexp.2006.03.006_bib111","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/0169-4758(96)10017-X","article-title":"Topoisomerases in Kinetoplastids","volume":"12","author":"Burri","year":"1996","journal-title":"Parasitol. Today"},{"key":"10.1016\/j.bbaexp.2006.03.006_bib112","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/sj.cdd.4400952","article-title":"Programmed cell death in the unicellular protozoan parasite Leishmania","volume":"9","author":"Lee","year":"2002","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.bbaexp.2006.03.006_bib113","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1038\/sj.cdd.4401435","article-title":"Camptothecin induced mitochondrial dysfunction leading to programmed cell death in unicellular hemoflagellate Leishmania donovani","volume":"11","author":"Sen","year":"2004","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.bbaexp.2006.03.006_bib114","doi-asserted-by":"crossref","first-page":"52366","DOI":"10.1074\/jbc.M406705200","article-title":"Camptothecin-induced imbalance in intracellular cation homeostasis regulates programmed cell death in unicellular hemoflagellate Leishmania donovani","volume":"279","author":"Sen","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbaexp.2006.03.006_bib115","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.molbiopara.2004.02.005","article-title":"Purification and properties of poly(ADP-ribose)polymerase from Crithidia fasciculata. Automodification and poly(ADP-ribosyl)ation of DNA topoisomerase","volume":"135","author":"Podesta","year":"2004","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.bbaexp.2006.03.006_bib116","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1126\/science.1112181","article-title":"Comparative genomics of Trypanosomatid parasitic protozoa","volume":"309","author":"El Sayed","year":"2005","journal-title":"Science"}],"container-title":["Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167478106000571?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167478106000571?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,18]],"date-time":"2019-04-18T11:21:51Z","timestamp":1555586511000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167478106000571"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3]]},"references-count":116,"journal-issue":{"issue":"3-4","published-print":{"date-parts":[[2006,3]]}},"alternative-id":["S0167478106000571"],"URL":"https:\/\/doi.org\/10.1016\/j.bbaexp.2006.03.006","relation":{},"ISSN":["0167-4781"],"issn-type":[{"value":"0167-4781","type":"print"}],"subject":[],"published":{"date-parts":[[2006,3]]}}}